Vanda Pharmaceuticals buy Truist Financial Co.
Start price
05.03.26
/
50%
€6.80
Target price
05.03.27
€15.49
Performance (%)
-30.82%
Price
18.08.26
€4.70
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Vanda Pharmaceuticals is performing very badly with a performance of -30.82%. This prediction currently runs until 05.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | 10.474% | 10.474% |
| iShares Core DAX® | -1.059% | 5.007% |
| iShares Nasdaq 100 | -2.387% | 0.864% |
| iShares Nikkei 225® | -4.361% | 1.211% |
| iShares S&P 500 | -1.778% | 1.391% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (VNDA) is now covered by Truist Financial Corporation. They set a "buy" rating and a $18.00 price target on the stock.
Ratings data for VNDA provided by MarketBeat